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Standfirst: The incidence and survival in people with head and neck cancer 
are changing, we argue that known risk factors may not fully explain these 
changes. 
 
 
  
  
What do we know about the aetiology of head and neck cancer?  
 
Head and neck cancers are the sixth most common cancers worldwide and 
an important cause of ill health.(1) Each year about 9000 cases are reported 
in the UK.(2) Survival is poor and despite advances in treatment, has not 
improved until recently.(3) The majority of head and neck cancers are 
squamous cell carcinomas, affecting the larynx, oropharynx and oral cavity. 
The aetiology is changing and this has implications for prevention and 
treatment. Twenty years ago, tobacco and alcohol consumption were 
considered to be the established risk factors and it was estimated that these 
risk factors accounted for about 75% of cases.(4) More recently human 
papillomavirus (HPV) has emerged as a likely cause of oropharyngeal 
cancer.(4) Here we argue that each cancer site is predicted differently by 
smoking, alcohol and sexual behaviour. We also suggest that these risk 
factors do not fully explain the changing pattern of disease observed in the 
UK. 
 
 
Trends in UK incidence and risk factor profiles in a large contemporary 
cohort could offer clues to the changing aetiology? 
 
We present recent data on trends in disease incidence and risk factors in the 
United Kingdom (UK) using the rolling 3-year age standardised rate per 
100,000, obtained from Cancer Research UK (2) in September 2016, UK 
trends in smoking,(5) sexual behaviours,(6) and alcohol (7–9) and the risk 
  
factor profiles of incident cases from a large NIHR funded UK-based clinical 
cohort study of head and neck cancer called Head and Neck 5000 
(H&N5000). The cohort is described in detail elsewhere.(10) Briefly, we 
recruited people with a new diagnosis of head and neck cancer and obtained 
wide ranging consent including agreement to collect clinical and longitudinal 
data, to store and analyse biological samples and for ongoing record linkage. 
Prior to treatment, participants completed questionnaires on health and 
lifestyle, quality of life and sexual history. The key variables used in this 
analysis were anatomical site (grouped according to ICD-10 code), age, 
gender and participant reported current smoking status, current drinking (units 
per week alcohol consumed) and history of giving oral sex. Alcohol 
consumption was categorized using the revised UK Department of Health 
guidelines (11) and higher thresholds defined by the ‘Institute of Alcohol 
Studies’ (12) resulting in four categories: ‘Non-drinkers’ (0 units/week), 
‘Moderate’ (>0 and ≤14 units/week), ‘Hazardous’ (Females >14 and ≤35, 
Males >14 and ≤50 units/week) and ‘Harmful’ (Females >35, Males >50 
units/week). The data were collected in 76 centres throughout the UK. Forty 
nine percent of all people with a cancer, attending the Head and Neck Cancer 
MDT (Multi Disciplinary Team Clinic), were recruited. Skin cancers and 
lymphomas affecting the head and neck were excluded. The results for 2,615 
people diagnosed with cancer of the oral cavity, oropharynx or larynx from 
April 2011 to December 2014 and with complete data are presented (Figure 
1). 
 
 
  
Laryngeal cancer – less of the same? 
 
In the UK the incidence of laryngeal cancer declined by nearly 20% between 
1990 and 2013, but this decline has levelled off since 2002.(2) People 
enrolled in H&N5000 who have laryngeal cancer are predominantly older, 
male smokers. Half of these people consume hazardous amounts of alcohol 
and a quarter report that they have never given oral sex. The established risk 
factors of smoking (90% had smoked) and alcohol (74% currently drank 
alcohol) are common behaviours amongst this recently diagnosed cohort of 
people with laryngeal cancer (see Figure 1).  
  
This pattern of behaviours is consistent with the risk factors reported in a large 
international consortium of case-control studies.(13) The consortium 
estimated that the joint effects of tobacco and alcohol use accounted for 89% 
of laryngeal cancers.(13) There was a substantial decline in the prevalence of 
smoking in most parts of the world between 1980 and 2012.(14) In the UK in 
1980, 42% of men and 36% of women reported smoking compared with 20% 
of men and 19% of women in 2010.(5) Longer-term trends in alcohol 
consumption are more difficult to interpret as UK Office of National Statistics 
data was irregular until 2005. The British Beer and Pub Association data from 
1990 to 2013 show no marked change in litres of alcohol consumed per 
person per year in the UK.(8) The falling incidence of laryngeal cancer in the 
UK may be linked to the reduction in smoking rates but the role of alcohol is 
less clear. 
 
  
 
Oropharyngeal cancer – just a consequence of the sexual revolution? 
 
In the last twenty years the incidence of oropharyngeal cancer in the UK has 
more than trebled. This increase is most marked in younger people. People 
with oropharyngeal cancer in the H&N5000 study are younger, less likely to 
smoke and more likely to have given oral sex than those with laryngeal 
cancer. Ninety three percent of people with oropharyngeal cancer had given 
oral sex (93% of men and 90% of women). Men were more likely than women 
to have had more than five oral sex partners (44% of men and 13% of 
women). The established risk factors of smoking and alcohol consumption are 
common (72% had smoked and 74% currently drink alcohol) but smoking is 
not as common as in those with laryngeal cancer.  
 
While transmission of HPV to the upper aerodigestive tract is thought to be 
through oral sexual contact the epidemiologic evidence of the role of sexual 
behaviour in head and neck cancer aetiology is inconsistent. A recent meta-
analysis examining the association between sexual behaviour and head and 
neck cancer reported no association with oral sex practices (but 12 of 17 
studies combined oral cavity and oropharynx cancers).(15) A case control 
study that just included people with oropharyngeal cancer showed that they 
were more likely than controls to have ever had oral sex and to have had 
multiple oral sex partners.(16) 
 
The profile of sexual behaviour for people with oropharyngeal tumours is 
  
markedly different from that for people with laryngeal cancer. It suggests a 
sexually transmitted aetiology but there are inconsistencies that make this 
association more complicated. The reported prevalence of oral sex with a 
partner of the opposite gender increased between the first UK National 
Survey of Sexual Attitudes and Lifestyles (6) Survey-1 (1990-91) and Survey -
2 (1999-2001) but plateaued in Survey-3 (2010-2012). Furthermore men 
reported little change in number of female oral sexual partners over the 
lifetime or the number of female oral sexual partners in the past year between 
Surveys-2 and -3 (1999 -2012).(6) Thus recent changes in sexual behaviour 
do not mirror the continued rise in the incidence of oropharyngeal cancer. 
 
Sexual behaviour may explain some of the increase in incidence of 
oropharyngeal cancer in the UK, it does not seem to account for all of this 
change. A recent study in the UK found there was no change in the proportion 
of HPV-attributable cases over time (2002-2011) however, during the same 
period, the incidence of oropharyngeal cancer doubled and similar findings 
have been made elsewhere in Europe.(17)  HPV has an important role in the 
continuing increase in incidence of oropharyngeal cancer, but this may not be 
explained by changes in sexual behaviour and HPV infection alone.  
 
 
Oral cavity cancer – different again? 
 
In the UK the incidence of oral cavity cancer has risen by 50% since 1990 
(Figure 1). In Figure 1 we show that people with oral cavity cancer in the 
  
H&N5000 study differed from those with laryngeal and oropharyngeal cancer. 
They were younger, more likely to be female and less likely to smoke than 
people with laryngeal cancer, but no more likely to have given oral sex. The 
prevalence of the established risk factors of smoking and alcohol was similar 
to that observed in people with oropharyngeal cancer but again less for giving 
oral sex. Oral cavity cancer is not typically associated with HPV infection (15) 
and the risk factor profile for people with oral cavity cancer does not suggest 
aetiology related to sexual behaviour. 
 
Previous studies suggest that smoking and alcohol have a multiplicative 
interaction and that the joint behaviours account for the majority of cases of 
oral cavity cancer (64%).(18) The decline in the prevalence of smoking in the 
UK should have resulted in a decline in the incidence of oral cavity cancer (as 
observed in laryngeal cancer).  
 
Though between 2005 and 2013 there has been little change in drinking 
behaviour in people aged over 64 in the UK (8) data from the beer and pub 
association (8) suggest that alcohol consumption doubled from 1950 to 1990. 
This trend is consistent with data from 1979 to 2005 that show hospital 
admissions and mortality from alcohol-induced liver disease in England have 
increased. (9) Furthermore, lifetime consumption appears to be important as 
the greater the number of years drinking varies by site, the risk of oral and 
pharyngeal cancer being higher than that for laryngeal cancer.(19) So longer 
term trends in alcohol consumption could explain some of the observed 
increase in incidence of oral cancer. 
  
 
Interestingly, we observed a high proportion of women in H&N5000 with oral 
cavity cancer and a third of these women have never smoked and a third did 
not currently consume alcohol and 42% had never given oral sex 
(supplementary table). These data suggest that this increase in the incidence 
in oral cancer may (in part) represent an emerging and distinct clinical entity 
of unknown aetiology.  
 
 
Head and neck cancer – a tale of three cancers? 
 
We used three sources to explain recent trends in the incidence of head and 
neck squamous cell cancers in the UK, past risk factors, recent changes in 
the risk factors and current exposure in a large UK cohort. The data we have 
are imperfect but they represent the most contemporary UK data for these 
cancers. Changes in smoking, alcohol and HPV infection related to sexual 
behaviour explain some of the observed changes in incidence of head and 
neck cancer. The reduction in laryngeal cancer incidence parallels the decline 
in smoking, but oral cancer and oropharyngeal cancer have not declined. 
Oropharyngeal cancer is associated with sexual behaviour and HPV but 
recent data suggest this is not the complete explanation. Oral cancer 
incidence has increased as has long term trends in alcohol consumption and 
alcohol-related mortality but this may not explain all of the change in 
incidence. The divergent trends in incidence and striking differences in the 
risk profile for people with squamous cell cancers at each of the three sites 
  
suggest important differences in the main aetiological drivers for each cancer.  
 
This is important because aetiology may predict treatment response and 
prognosis. People with HPV positive oropharyngeal cancers have better 
survival than those with HPV negative cancers and trials are underway to 
assess the impact of modifying treatment according to HPV status. Improved 
understanding of the changing aetiology of head and neck cancer may 
therefore allow refinements to treatment modality and intensity and better 
targeted preventive efforts.  
 
Combined analysis of head and neck cancers from different sites may be 
unhelpful when trying to tease out the aetiology and prognosis of these 
heterogeneous cancers. H&N5000 has recently contributed to a genome wide 
association study of head and neck cancers which points to aetiological 
differences between head and neck cancers. The study identified seven new 
genetic loci - one was linked to oropharyngeal cancer and six with oral cavity 
cancer.(20)  Future studies are needed to characterise tumours 
epidemiologically, genetically and epigenetically. This will help to confirm the 
role of risk factors and identify tumours with different prognoses that may 
respond differently to treatment. Large bio-collections set up to study 
prognosis (such as H&N5000) will be required to do this. 
 
 
 
  
  
 
Key messages 
• The incidence of laryngeal cancer is falling in the UK and is consistent with 
the decline in tobacco consumption  
• The incidence of oropharyngeal cancer is rising rapidly in the UK and is 
associated with sexual behaviour and Human Papilloma Virus  
• Patients with oropharynx cancer report increased numbers of lifetime 
sexual partners and oro-genital sexual contact compared with [patients 
who have larynx and oral cavity cancer 
•  Whether HPV OPSCC is a sexually transmitted disease has not been 
firmly established 
• The incidence of oral cavity cancer is increasing in the UK and may reflect 
long term trends in alcohol consumption  
 
 
  
  
Figure 1: Change in incidence of Larynx, Oropharynx and Oral Cavity cancers, key risk factors and descriptives for H&N5000 
Cohort 
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1 – Rolling 3-year age standardised rate/100,000, source: Calculated by the Statistical Information Team at Cancer Research UK 
upon request, September 2016 (2). 
2 – Proportion of adults smoking, sources: Action on Smoking and health (February 2016), Opinions and Lifestyle Survey, and the 
General Household/General Lifestyle Surveys (10) 
3 – Proportion given or received oral sex in past year (data collected 1990, 2000, 2010), sources: The National Survey of Sexual 
Attitudes and Lifestyles (NATSAL) 1, 2 & 3 (15) 
4 – Litres of alcohol consumed per person per year, sources: Health & Social Care Information Centre, HM Revenue and Customs 
and Excise (11)
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Supplementary Table 1: Variation in deprivation, behaviour and age by 
gender and tumour site  
 Larynx Oropharynx Oral cavity 
  
Males 
N=535 
Females 
N=92 
Males 
N=924 
Females 
N=251 
Males 
No. 502 
Females 
No. 311 
Quintile of 2010 IMD      
Least deprived 94 (17.6%) 14 (15.2%) 176 (19.1%) 54 (21.5%) 111 (22.1%) 71 (22.8%) 
Less 106 (19.8%) 15 (16.3%) 216 (23.4%) 39 (15.5%) 96 (19.1%) 63 (20.3%) 
Middle 114 (21.3%) 15 (16.3%) 217 (23.5%) 60 (23.9%) 105 (20.9%) 72 (23.2%) 
More 108 (20.2%) 18 (19.6%) 178 (19.3%) 59 (23.5%) 74 (14.7%) 51 (16.4%) 
Most deprived 113 (21.1%) 30 (32.6%) 137 (14.8%) 39 (15.5%) 116 (23.1%) 54 (17.4%) 
Alcohol consumption      
Non drinker 117 (21.9%) 42 (45.7%) 203 (22.0%) 97 (38.7%) 110 (21.9%) 114 (36.7%) 
Moderate 120 (22.4%) 22 (23.9%) 203 (22.0%) 72 (28.7%) 92 (18.3%) 92 (29.6%) 
Hazardous  227 (42.4%) 18 (19.6%) 386 (41.8%) 54 (21.5%) 213 (42.4%) 60 (19.3%) 
Harmful  71 (13.3%) 10 (10.9%) 132 (14.3%) 28 (11.2%) 87 (17.3%) 45 (14.5%) 
Smoking status      
Never 47 (8.8%) 12 (13.0%) 257 (27.8%) 74 (29.5%) 107 (21.3%) 100 (32.2%) 
Former 380 (71.0%) 62 (67.4%) 518 (56.1%) 136 (54.2%) 270 (53.8%) 142 (45.7%) 
Current user 108 (20.2%) 18 (19.6%) 149 (16.1%) 41 (16.3%) 125 (24.9%) 69 (22.2%) 
Age at consent      
<50 years old 28 (5.2%) 9 (9.8%) 154 (16.7%) 45 (17.9%) 91 (18.1%) 48 (15.4%) 
50-60 117 (21.9%) 28 (30.4%) 364 (39.4%) 108 (43.0%) 130 (25.9%) 78 (25.1%) 
60-70 211 (39.4%) 34 (37.0%) 295 (31.9%) 68 (27.1%) 166 (33.1%) 97 (31.2%) 
70+ 179 (33.5%) 21 (22.8%) 111 (12.0%) 30 (12.0%) 115 (22.9%) 88 (28.3%) 
  
Ever performed oral sex*      
Never 90 (23.9%) 27 (41.5%) 46 (6.6%) 20 (10.5%) 80 (23.4%) 96 (41.6%) 
1-5 people 206 (54.8%) 33 (50.8%) 348 (49.6%) 147 (77.0%) 185 (54.1%) 117 (50.7%) 
>5 people 80 (21.3%) 5 (7.7%) 308 (43.9%) 24 (12.6%) 77 (22.5%) 18 (7.8%) 
Missing 159 27 222 60 160 80 
*- People who did not report their oral sex behaviour were excluded from the calculated 
proportions 
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